In an earnest pursuit of scientific advancement in this era of rapid progress in science and medicine, there remains a dark side that we cannot overlook. This dark side poses a significant threat to health, engulfing us with worry and fear about our future well-being. This concern revolves around the resurgence of drug-resistant pathogens, such as multidrug-resistant bacterial strains, fungi, and parasites. This looming fear has compelled scientists to urgently delve into the minutiae to find radical solutions. Their aim is to develop new, effective compounds against microbes or sustain studies and modify existing substances to prevent the spread of diseases and shield humanity from threats invisible to the naked eye.
Nanotechnology presents an innovative solution, allowing for the modification of key properties of materials, including metallic nanoparticles obtained through various methods. Among the best of these methods, biogenic synthesis stands out as a reliable approach in manufacturing metallic nanoparticles. Moreover, this method is considered environmentally friendly compared to other chemical and physical methods, making it an intriguing option for research and development in the field of nanotechnology, medicine, and industry.
Silver is one of these vital substances known for thousands of years for its effectiveness in combating infections such as burn infections, bone infections, urinary tract infections, and central venous catheter-related infections. Recently, silver nanoparticles have gained prominence for their potent antimicrobial activity, making silver-based antimicrobial materials a common choice. Current studies aim to understand their mechanisms of action more precisely, further enhancing their effectiveness and specificity, thus making them a powerful tool in our ongoing battle against drug-resistant diseases.